Found 5 hits for monomerid = 50323736 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50323736
(2-(3-(2-methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydro...)Show SMILES COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2CCCCc2c1=O |(21.65,-14.78,;20.32,-15.55,;20.33,-17.09,;21.66,-17.85,;21.67,-19.4,;20.33,-20.18,;19,-19.41,;19,-17.86,;17.67,-17.1,;17.66,-15.56,;18.99,-14.78,;18.99,-13.24,;20.32,-12.47,;21.66,-13.23,;20.32,-10.93,;21.65,-10.15,;22.98,-10.92,;24.31,-10.14,;24.31,-8.6,;25.64,-7.82,;25.63,-6.28,;24.27,-5.51,;22.94,-6.3,;22.96,-7.84,;21.64,-8.62,;16.33,-14.79,;15.01,-15.56,;13.68,-14.78,;12.35,-15.56,;12.35,-17.1,;13.68,-17.86,;15.01,-17.1,;16.34,-17.87,;16.33,-19.41,)| Show InChI InChI=1S/C25H23N5O3S/c1-33-22-9-5-4-8-21(22)30-24(32)17-6-2-3-7-18(17)29-25(30)34-15-23(31)28-16-10-11-19-20(14-16)27-13-12-26-19/h4-5,8-14H,2-3,6-7,15H2,1H3,(H,28,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
| Article PubMed
| n/a | n/a | 3.44E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Research Council-Laboratory of Molecular Biology
Curated by ChEMBL
| Assay Description Inhibition of p110alpha |
Nat Chem Biol 6: 117-24 (2010)
Article DOI: 10.1038/nchembio.293 BindingDB Entry DOI: 10.7270/Q2KP82CK |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50323736
(2-(3-(2-methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydro...)Show SMILES COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2CCCCc2c1=O |(21.65,-14.78,;20.32,-15.55,;20.33,-17.09,;21.66,-17.85,;21.67,-19.4,;20.33,-20.18,;19,-19.41,;19,-17.86,;17.67,-17.1,;17.66,-15.56,;18.99,-14.78,;18.99,-13.24,;20.32,-12.47,;21.66,-13.23,;20.32,-10.93,;21.65,-10.15,;22.98,-10.92,;24.31,-10.14,;24.31,-8.6,;25.64,-7.82,;25.63,-6.28,;24.27,-5.51,;22.94,-6.3,;22.96,-7.84,;21.64,-8.62,;16.33,-14.79,;15.01,-15.56,;13.68,-14.78,;12.35,-15.56,;12.35,-17.1,;13.68,-17.86,;15.01,-17.1,;16.34,-17.87,;16.33,-19.41,)| Show InChI InChI=1S/C25H23N5O3S/c1-33-22-9-5-4-8-21(22)30-24(32)17-6-2-3-7-18(17)29-25(30)34-15-23(31)28-16-10-11-19-20(14-16)27-13-12-26-19/h4-5,8-14H,2-3,6-7,15H2,1H3,(H,28,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
| Article PubMed
| n/a | n/a | 4.23E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Research Council-Laboratory of Molecular Biology
Curated by ChEMBL
| Assay Description Inhibition of p110beta |
Nat Chem Biol 6: 117-24 (2010)
Article DOI: 10.1038/nchembio.293 BindingDB Entry DOI: 10.7270/Q2KP82CK |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50323736
(2-(3-(2-methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydro...)Show SMILES COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2CCCCc2c1=O |(21.65,-14.78,;20.32,-15.55,;20.33,-17.09,;21.66,-17.85,;21.67,-19.4,;20.33,-20.18,;19,-19.41,;19,-17.86,;17.67,-17.1,;17.66,-15.56,;18.99,-14.78,;18.99,-13.24,;20.32,-12.47,;21.66,-13.23,;20.32,-10.93,;21.65,-10.15,;22.98,-10.92,;24.31,-10.14,;24.31,-8.6,;25.64,-7.82,;25.63,-6.28,;24.27,-5.51,;22.94,-6.3,;22.96,-7.84,;21.64,-8.62,;16.33,-14.79,;15.01,-15.56,;13.68,-14.78,;12.35,-15.56,;12.35,-17.1,;13.68,-17.86,;15.01,-17.1,;16.34,-17.87,;16.33,-19.41,)| Show InChI InChI=1S/C25H23N5O3S/c1-33-22-9-5-4-8-21(22)30-24(32)17-6-2-3-7-18(17)29-25(30)34-15-23(31)28-16-10-11-19-20(14-16)27-13-12-26-19/h4-5,8-14H,2-3,6-7,15H2,1H3,(H,28,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
| MMDB PDB Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description Inhibition of PI3Kdelta |
J Med Chem 55: 8559-81 (2012)
Article DOI: 10.1021/jm300847w BindingDB Entry DOI: 10.7270/Q2SN0B47 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50323736
(2-(3-(2-methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydro...)Show SMILES COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2CCCCc2c1=O |(21.65,-14.78,;20.32,-15.55,;20.33,-17.09,;21.66,-17.85,;21.67,-19.4,;20.33,-20.18,;19,-19.41,;19,-17.86,;17.67,-17.1,;17.66,-15.56,;18.99,-14.78,;18.99,-13.24,;20.32,-12.47,;21.66,-13.23,;20.32,-10.93,;21.65,-10.15,;22.98,-10.92,;24.31,-10.14,;24.31,-8.6,;25.64,-7.82,;25.63,-6.28,;24.27,-5.51,;22.94,-6.3,;22.96,-7.84,;21.64,-8.62,;16.33,-14.79,;15.01,-15.56,;13.68,-14.78,;12.35,-15.56,;12.35,-17.1,;13.68,-17.86,;15.01,-17.1,;16.34,-17.87,;16.33,-19.41,)| Show InChI InChI=1S/C25H23N5O3S/c1-33-22-9-5-4-8-21(22)30-24(32)17-6-2-3-7-18(17)29-25(30)34-15-23(31)28-16-10-11-19-20(14-16)27-13-12-26-19/h4-5,8-14H,2-3,6-7,15H2,1H3,(H,28,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
| MMDB PDB Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Research Council-Laboratory of Molecular Biology
Curated by ChEMBL
| Assay Description Inhibition of p110delta |
Nat Chem Biol 6: 117-24 (2010)
Article DOI: 10.1038/nchembio.293 BindingDB Entry DOI: 10.7270/Q2KP82CK |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50323736
(2-(3-(2-methoxyphenyl)-4-oxo-3,4,5,6,7,8-hexahydro...)Show SMILES COc1ccccc1-n1c(SCC(=O)Nc2ccc3nccnc3c2)nc2CCCCc2c1=O |(21.65,-14.78,;20.32,-15.55,;20.33,-17.09,;21.66,-17.85,;21.67,-19.4,;20.33,-20.18,;19,-19.41,;19,-17.86,;17.67,-17.1,;17.66,-15.56,;18.99,-14.78,;18.99,-13.24,;20.32,-12.47,;21.66,-13.23,;20.32,-10.93,;21.65,-10.15,;22.98,-10.92,;24.31,-10.14,;24.31,-8.6,;25.64,-7.82,;25.63,-6.28,;24.27,-5.51,;22.94,-6.3,;22.96,-7.84,;21.64,-8.62,;16.33,-14.79,;15.01,-15.56,;13.68,-14.78,;12.35,-15.56,;12.35,-17.1,;13.68,-17.86,;15.01,-17.1,;16.34,-17.87,;16.33,-19.41,)| Show InChI InChI=1S/C25H23N5O3S/c1-33-22-9-5-4-8-21(22)30-24(32)17-6-2-3-7-18(17)29-25(30)34-15-23(31)28-16-10-11-19-20(14-16)27-13-12-26-19/h4-5,8-14H,2-3,6-7,15H2,1H3,(H,28,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
| Article PubMed
| n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Medical Research Council-Laboratory of Molecular Biology
Curated by ChEMBL
| Assay Description Inhibition of p110gamma |
Nat Chem Biol 6: 117-24 (2010)
Article DOI: 10.1038/nchembio.293 BindingDB Entry DOI: 10.7270/Q2KP82CK |
More data for this Ligand-Target Pair | |